Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Times Interest Earned (2022 - 2026)

Centessa Pharmaceuticals has reported Times Interest Earned over the past 4 years, most recently at -$24.38 for Q4 2025.

  • Quarterly Times Interest Earned rose 18.95% to -$24.38 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$18.12 through Dec 2025, up 9.04% year-over-year, with the annual reading at -$18.12 for FY2025, 9.04% up from the prior year.
  • Times Interest Earned was -$24.38 for Q4 2025 at Centessa Pharmaceuticals, down from -$18.61 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$10.7 in Q1 2025 and troughed at -$41.39 in Q2 2022.
  • The 4-year median for Times Interest Earned is -$18.92 (2025), against an average of -$21.46.
  • Year-over-year, Times Interest Earned soared 53.63% in 2023 and then crashed 119.79% in 2024.
  • A 4-year view of Times Interest Earned shows it stood at -$18.88 in 2022, then rose by 27.52% to -$13.69 in 2023, then crashed by 119.79% to -$30.08 in 2024, then increased by 18.95% to -$24.38 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Times Interest Earned are -$24.38 (Q4 2025), -$18.61 (Q3 2025), and -$18.95 (Q2 2025).